Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (91-100 of 205) with videos related to

Pageof 21
Sort By:
American Journal of Clinical Oncology|October 1, 2010
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981Scott T Tagawa, Matthew I Milowsky, Stephanie Jeske, et al.
Journal of the National Cancer Institute|February 16, 2013
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapyAndrea B Apolo, Irina Ostrovnaya, Susan Halabi, et al.
Cancer|October 15, 2013
Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006Matthew E Nielsen, Angela B Smith, Anne-Marie Meyer, et al.
Cancer|October 1, 2008
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experienceAtreya Dash, Joseph A Pettus, Harry W Herr, et al.
European Urology|May 31, 2023
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker SelectionJoshua J Meeks, Peter C Black, Matthew Galsky, et al.
Clinical Genitourinary Cancer|May 3, 2014
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinomaGregory R Pond, Matthew I Milowsky, Michael P Kolinsky, et al.
Cancer|August 12, 2009
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinomaDavid J Gallagher, Matthew I Milowsky, Alexia Iasonos, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
JCI Insight|October 5, 2016
Claudin-low bladder tumors are immune infiltrated and actively immune suppressedJordan Kardos, Shengjie Chai, Lisle E Mose, et al.
ACS Nano|September 27, 2016
The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type TumorsLei Miao, Jay M Newby, C Michael Lin, et al.
Pageof 21

Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
American Journal of Clinical Oncology|October 1, 2010
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981Scott T Tagawa, Matthew I Milowsky, Stephanie Jeske, et al.
Journal of the National Cancer Institute|February 16, 2013
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapyAndrea B Apolo, Irina Ostrovnaya, Susan Halabi, et al.
Cancer|October 15, 2013
Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006Matthew E Nielsen, Angela B Smith, Anne-Marie Meyer, et al.
Cancer|October 1, 2008
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experienceAtreya Dash, Joseph A Pettus, Harry W Herr, et al.
European Urology|May 31, 2023
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker SelectionJoshua J Meeks, Peter C Black, Matthew Galsky, et al.
Clinical Genitourinary Cancer|May 3, 2014
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinomaGregory R Pond, Matthew I Milowsky, Michael P Kolinsky, et al.
Cancer|August 12, 2009
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinomaDavid J Gallagher, Matthew I Milowsky, Alexia Iasonos, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
JCI Insight|October 5, 2016
Claudin-low bladder tumors are immune infiltrated and actively immune suppressedJordan Kardos, Shengjie Chai, Lisle E Mose, et al.
ACS Nano|September 27, 2016
The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type TumorsLei Miao, Jay M Newby, C Michael Lin, et al.
Pageof 21